Press Releases

UK life science backs May's plan to remain part of EMA

BIA welcomes the Prime Minister’s announcement today that the UK will seek to explore with the EU, the terms on which the UK could remain part the European Medicines Agency, abide by the rules of the agency and make an appropriate financial contribution.

Brexit Health Alliance Campaign - The Impact of Brexit: Patient Access to Medical Research

Children could be excluded from lifesaving clinical trials for cancer treatments when the UK leaves the EU, according to the Brexit Health Alliance.

BIA launches new Genomics Advisory Committee at annual Committee Summit

Today the UK Bioindustry Association (BIA) launches its newest Advisory Committee, focused on the issue of genomics.

Harren Jhoti receives BIA Lifetime Achievement Award at Annual Gala Dinner

Harren Jhoti, co-founder of Astex and President and CEO of Astex Pharmaceuticals, was awarded the BioIndustry Association (BIA) Lifetime Achievement Award at the BIA’s annual Gala Dinner last night.


Member News

Horizon Discovery and Genewell Biotechnology enter into partnership for distribution of diagnostic reference standards for the Chinese market

Partnership immediately provides Horizon with deeper access to Chinese diagnostic assay manufacturers and potential OEM agreements as part of stated global leadership strategy.

Astex Continues to Deliver in Oncology as Erdafitinib, a Potential New Treatment for Metastatic Urothelial Cancer, Receives US FDA Breakthrough Therapy Designation

Astex Pharmaceuticals , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its pharmaceutical collaborator, Janssen Pharmaceutica N.V. (Janssen), has been granted Breakthrough Therapy Designation by the US FDA for erdafitinib in the treatment of metastatic urothelial cancer.

Domainex appoints Dr Bodo Spori as Head of Business Development for Europe

Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.

NovaBiotics’ Lynovex receives Fast Track Designation for Cystic Fibrosis Exacerbations

NovaBiotics Ltd (NovaBiotics), a clinical-stage anti-infectives biotechnology company, announces receipt of Fast Track Designation (FTD) for its cystic fibrosis (CF) therapy, Lynovex®, from the United States Food and Drug Administration (FDA).


BIA blog

Video of the Week - Dr Elisa Passini on winning the 2017 3Rs Prize

Dr Elisa Passini (Department of Computer Science, University of Oxford) is the 2017 3Rs Prize winner. Here she discusses her prize-winning research into the development of computer models of human cardiac cells for the prediction of drug-induced cardiotoxicity. These have the potential to replace animal models in pre-clinical trials, as well as providing a more accurate model of human cardiac activity.

BIA visits an animal research facility

The BIA team recently visited the animal research facilities at King’s College London. It was the first time many in the team had visited animal research facilities to see how pre-clinical research looks in practice.

Steady as she goes in the Spring Statement

Dr Martin Turner, BIA Policy and Projects Manager, takes a look at today's Spring Statement from Chancellor Phillip Hammond and its implications for the bioscience sector.

CEO Update: Monday 12 March

Today, the Business Secretary Greg Clark has announced that the government is investing over £300 million from its Industrial Strategy Challenge Fund (ISCF) to bring together the UK’s world-class research expertise with business investment to develop technologies and industries that can help the UK prepare for the challenge of an ageing society. £210 million will be invested in the ‘data to early diagnosis and precision medicine’ challenge which will see the UK lead the world in the development of innovative new diagnostic tools, medical products and treatments.


Our publications

Please find a selection of featured BIA publications below. To see our full publications library, click here

BIA members' guide to the Patent Box

This guide explains how the Patent Box regime works and what bioscience companies should consider when choosing if and when to elect into it.

Influencing and shaping our sector, BIA update - October 2017 - January 2018

An overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders from October 2017 to January 2018.

Pipeline Progressing: The UK's Global Bioscience Cluster in 2017

A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.

BIA Best practice guide for communicating R&D

Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.